US 11,690,628 B2
Occlusive devices
Vincent Divino, Mission Viejo, CA (US); Earl Frederick Bardsley, San Clemente, CA (US); Richard Rhee, Anaheim, CA (US); Madhur Arunrao Kadam, Lake Forest, CA (US); and Julie Kulak, Trabuco Canyon, CA (US)
Assigned to COVIDIEN LP, Mansfield, MA (US)
Filed by Covidien LP, Mansfield, MA (US)
Filed on May 15, 2019, as Appl. No. 16/412,967.
Application 16/412,967 is a continuation of application No. 14/079,591, filed on Nov. 13, 2013, granted, now 10,327,781.
Claims priority of provisional application 61/725,768, filed on Nov. 13, 2012.
Prior Publication US 2019/0282242 A1, Sep. 19, 2019
Int. Cl. A61B 17/12 (2006.01); A61F 2/95 (2013.01)
CPC A61B 17/12113 (2013.01) [A61B 17/1219 (2013.01); A61B 17/12022 (2013.01); A61B 17/12118 (2013.01); A61B 17/12159 (2013.01); A61B 17/12163 (2013.01); A61B 17/12186 (2013.01); A61F 2/95 (2013.01); A61B 17/1214 (2013.01); A61B 2017/1205 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A method for treatment of an aneurysm, comprising:
intravascularly delivering a first expandable component to a cavity of the aneurysm, the first expandable component defined by a sidewall that encloses an interior region;
expanding the first expandable component in the aneurysm cavity via introduction of fluid into the interior region, thereby increasing a volume of the interior region, or the first expandable component, wherein at least a portion of the first expandable component contacts an inner surface of the aneurysm wall; and
positioning a second expandable component between the first expandable component and the aneurysm wall, the second expandable component comprising a coil.